Skip to main content
Drug bottle and Pill

Compare Jardiance vs. Wegovy

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Jardiance (empagliflozin) and Wegovy (semaglutide) are both medications that can help with conditions related to Type 2 diabetes and heart health, but they belong to different medication classes and have distinct uses. Jardiance is a sodium-glucose cotransporter-2 (SGLT2) inhibitor taken orally once a day, primarily used to manage blood sugar levels in people with Type 2 diabetes and to reduce the risk of heart and kidney complications. It can also cause weight loss as a side effect, though it is not approved for weight loss. Common side effects include urinary tract infections and yeast infections. On the other hand, Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist injected once weekly, specifically approved for long-term weight management in adults and children with a high body mass index (BMI), and to lower the risk of heart problems in adults with heart disease. Wegovy's common side effects include nausea, diarrhea, and stomach pain. Both Jardiance and Wegovy are available only as brand-name medications. Both medications can interact with diabetes medications, with an increased risk for low blood sugar.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.